Your browser doesn't support javascript.
loading
Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen, Tran B; Sakata-Yanagimoto, Mamiko; Fujisawa, Manabu; Nuhat, Sharna Tanzima; Miyoshi, Hiroaki; Nannya, Yasuhito; Hashimoto, Koichi; Fukumoto, Kota; Bernard, Olivier A; Kiyoki, Yusuke; Ishitsuka, Kantaro; Momose, Haruka; Sukegawa, Shinichiro; Shinagawa, Atsushi; Suyama, Takuya; Sato, Yuji; Nishikii, Hidekazu; Obara, Naoshi; Kusakabe, Manabu; Yanagimoto, Shintaro; Ogawa, Seishi; Ohshima, Koichi; Chiba, Shigeru.
Afiliação
  • Nguyen TB; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. schiba-tky@umin.net sakatama-tky@umin.net.
  • Fujisawa M; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Nuhat ST; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Miyoshi H; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Nannya Y; Department of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka, Japan.
  • Hashimoto K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
  • Fukumoto K; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Bernard OA; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Kiyoki Y; INSERM U1170, Gustave Roussy, Université Paris-Saclay, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
  • Ishitsuka K; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Momose H; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Sukegawa S; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Shinagawa A; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Suyama T; Department of Hematology, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
  • Sato Y; Department of Hematology, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
  • Nishikii H; Department of Hematology, Tsukuba Memorial Hospital, Tsukuba, Ibaraki, Japan.
  • Obara N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Kusakabe M; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Yanagimoto S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Ogawa S; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
  • Ohshima K; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Chiba S; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
Cancer Res ; 80(9): 1875-1884, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32107212

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfoma de Células T / Proteínas Proto-Oncogênicas / Proteína rhoA de Ligação ao GTP / Proteínas de Ligação a DNA / Dasatinibe / Linfadenopatia Imunoblástica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfoma de Células T / Proteínas Proto-Oncogênicas / Proteína rhoA de Ligação ao GTP / Proteínas de Ligação a DNA / Dasatinibe / Linfadenopatia Imunoblástica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos